A specific protein on the surface of immune cells taken from the tonsils indicated they were reservoir cells.

The Centers for Disease Control and Prevention estimates that about 36,400 people contracted HIV in 2018.

Results from randomized clinical trials of the antiviral drug are starting to become available.

Merck’s investigational antiretroviral is a reverse transcriptase¬ translocation inhibitor.

Researchers found women are less likely than men to accept a prescription for post-exposure prophylaxis after an assault.

The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.

Study participants treated with the monoclonal antibody had a 56% reduction in harmful cholesterol.

A majority of women interviewed in a small study expressed a preference for monthly injectable treatment over daily pills.

Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.